Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

Pfizer logo

Pfizer

Status

Completed

Conditions

Asthma
Pulmonary Disease, Chronic Obstructive

Treatments

Device: Diskus
Device: Twisthaler
Device: Miat Monohaler
Device: CRC-749

Study type

Observational

Funder types

Industry

Identifiers

NCT01033669
A9011071

Details and patient eligibility

About

Assessment of the inhalation profiles of four dry powder inhalers in patients with variable degrees of lung obstruction

Full description

Randomized to device sequence

Enrollment

57 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with a physician documented history or diagnosis of asthma for at least 6 months
  • Reversibility, defined as an increase in FEV1 at the Screening visit of greater than or equal to 12% and 200 mL
  • Subjects with a physician documented history or diagnosis of mild or severe Chronic Obstructive Pulmonary Disease

Exclusion criteria

  • Female subjects who are pregnant
  • Subjects who have a history of life-threatening asthma/COPD or who have experienced two or more exacerbations requiring hospitalization in the 12 months prior to screening
  • Evidence of lower respiratory tract infection
  • Subjects diagnosed with pulmonary fibrosis, bronchiectasis, pneumoconiosis, sarcoidosis or tuberculosis

Trial design

57 participants in 1 patient group

Dry Powder Inhalers
Treatment:
Device: CRC-749
Device: Miat Monohaler
Device: Twisthaler
Device: Diskus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems